Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 34Terminated 18Recruiting 14Active not recruiting 6Unknown 5Not yet recruiting 2Withdrawn 1Suspended 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1Gynecologic 1

Conditions

Breast Neoplasms 424Neoplasms 283Carcinoma, Non-Small-Cell Lung 268Colorectal Neoplasms 233Prostatic Neoplasms 173Lung Neoplasms 172Carcinoma, Hepatocellular 157Stomach Neoplasms 127Leukemia, Myeloid, Acute 119Pancreatic Neoplasms 117Multiple Myeloma 106Recurrence 98Uterine Cervical Neoplasms 95Squamous Cell Carcinoma of Head and Neck 88Neoplasm Metastasis 87Rectal Neoplasms 86Ovarian Neoplasms 80Triple Negative Breast Neoplasms 77Small Cell Lung Carcinoma 72Head and Neck Neoplasms 67Brain Neoplasms 67Esophageal Neoplasms 64Glioblastoma 63Endometrial Neoplasms 60Colonic Neoplasms 60Melanoma 57Hematologic Neoplasms 54Motor Activity 50Precursor Cell Lymphoblastic Leukemia-Lymphoma 48Glioma 46

Interventions

inavolisib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Interventional × Hereditary Sensory and Autonomic Neuropathies × Clear all
NCT07522697 2026-04-13

MITO END-4

National Cancer Institute, Naples

Phase 2 Not yet recruiting
48 enrolled
Gynecologic

Hereditary Sensory and Autonomic Neuropathies, Endometrial Neoplasms

NCT07137637 2025-08-22

HPB-092 for the Treatment of Relapsed and Refractory Acute Myeloid Leukemia

Hangzhou Polymed Biopharmaceuticals, Inc.

Phase 1 Not yet recruiting
60 enrolled
Other hematologic neoplasm

Hereditary Sensory and Autonomic Neuropathies, Recurrence, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡